切换至 "中华医学电子期刊资源库"

中华卫生应急电子杂志 ›› 2025, Vol. 11 ›› Issue (06) : 351 -355. doi: 10.3877/cma.j.issn.2095-9133.2025.06.007

论著

脓毒症相关急性胃肠损伤患者I-FABP、D-乳酸及炎症因子变化及意义
刘鑫1, 王文惠2,(), 吴守振3   
  1. 1716000 陕西延安,延安市人民医院消化内科
    2727400 陕西延安,陕西省洛川县中医医院内科
    3716000 陕西延安,延安市人民医院中心实验室
  • 收稿日期:2025-06-17 出版日期:2025-12-18
  • 通信作者: 王文惠

Implications of I-FABP, D-lactate and inflammatory cytokine changes in patients with sepsis related acute gastrointestinal injury

Xin Liu1, Wenhui Wang2,(), Shouzhen Wu3   

  1. 1Department of Gastroenterology, Yan'an People's Hospital Yan'an 716000, China
    2Department of Internal Medicine, Shaanxi Luochuan County Hospital of Traditional Chinese Medicine, Yan'an 727400 China
    3Central Laboratory, Yan'an People's Hospital, Yan'an 716000, China
  • Received:2025-06-17 Published:2025-12-18
  • Corresponding author: Wenhui Wang
引用本文:

刘鑫, 王文惠, 吴守振. 脓毒症相关急性胃肠损伤患者I-FABP、D-乳酸及炎症因子变化及意义[J/OL]. 中华卫生应急电子杂志, 2025, 11(06): 351-355.

Xin Liu, Wenhui Wang, Shouzhen Wu. Implications of I-FABP, D-lactate and inflammatory cytokine changes in patients with sepsis related acute gastrointestinal injury[J/OL]. Chinese Journal of Hygiene Rescue(Electronic Edition), 2025, 11(06): 351-355.

目的

探讨脓毒症相关急性胃肠损伤患者肠型脂肪酸结合蛋白(I-FABP)、D-乳酸及炎症因子检测价值。

方法

回顾性分析2021年1月至2024年12月延安市人民医院收治的80例脓毒症患者的病历资料,其中男性42例,女性38例;年龄32~70岁,平均(53.52±4.10)岁。根据相关急性胃肠损伤情况分为脓毒急性胃肠损伤组(n=25)和脓毒症非急性胃肠损伤组(n=55),根据最终急性胃肠损伤结果分为Ⅰ~Ⅱ级组(n=16),Ⅲ~Ⅳ级组(n=9)。所有患者行血清I-FABP、D-乳酸及炎症因子测定,分析血清I-FABP、D-乳酸及炎症因子变化情况及采用受试者工作特征(ROC)曲线分析其早期诊断价值。

结果

脓毒症相关急性胃肠损伤血清I-FABP、D-乳酸、C反应蛋白(CRP)、白介素-6(IL-6)及降钙素原(PCT)水平均显著高于脓毒症非胃肠损伤组(P<0.05);Ⅲ~Ⅳ级组患者血清I-FABP、D-乳酸、CRP、IL-6及PCT水平均显著高于Ⅰ~Ⅱ级组患者(P<0.05)。ROC曲线分析显示,血清I-FABP、D-乳酸及炎症因子对脓毒症患者相关急性胃肠损伤均具有一定的诊断价值,且联合检测的AUC为0.857,灵敏度为91.34%,特异度为94.65%,具有较高的诊断价值。

结论

血清I-FABP、D-乳酸及炎症因子联合检测可提高脓毒症相关急性胃肠损伤患者的诊断效能,可早期反映患者胃肠组织损伤。

Objective

To explore the value of detecting intestinal type fatty acid binding protein (I-FABP), D-lactate, and inflammatory factors in patients with sepsis-related acute gastrointestinal injury.

Methods

A retrospective analysis of medical records of 80 sepsis patients admitted to Yan'an People's Hospital from January 2021 to December 2024 was conducted, including 42 males and 38 females. The age ranged from 32 to 70 years, with an average of (53.52±4.10) years. According to the relevant acute gastrointestinal injury situation, the patients were divided into sepsis-related acute gastrointestinal injury group (n=25), sepsis-related non acute gastrointestinal injury group (n=55). According to the final results of acute gastrointestinal injury, they were divided into grade I-II group (n=16) and grade III-IV group (n=9). All patients were tested for serum I-FABP, D-lactate, and inflammatory factors, and the changes in serum I-FABP, D-lactate, and inflammatory factors were analyzed. The receiver operating characteristic (ROC) curve was used to analyze their early diagnostic value.

Results

The levels of serum I-FABP, D-lactate, C-reactive protein (CRP), interleukin-6 (IL-6), and procalcitonin (PCT) in sepsis related acute gastrointestinal injury group were significantly higher than those in sepsis-related non gastrointestinal injury group (P<0.05); The levels of serum I-FABP, D-lactate, CRP, IL-6, and PCT in patients with grade III-IV were significantly higher than those in patients with grade I-II (P<0.05); ROC curve analysis showed that serum I-FABP, D-lactate, and inflammatory factors all had certain diagnostic value for acute gastrointestinal injury related to sepsis patients, and the combined detection AUC was 0.857, sensitivity was 91.34%, and specificity was 94.65%, indicating high diagnostic value.

Conclusion

The combined detection of serum I-FABP, D-lactate and inflammatory factors can improve the diagnostic efficiency of sepsis related acute gastrointestinal injury and can early reflect gastrointestinal tissue damage in patients.

表1 两组I-FABP、D-乳酸及炎症因子水平比较(±s
表2 不同急性胃肠损伤分级I-FABP、D-乳酸及炎症因子水平比较(±s
图1 血清I-FABP、D-乳酸及炎症因子在脓毒症相关急性胃肠损伤中的ROC曲线注:ROC为受试者工作特征,I-FABP为肠型脂肪酸结合蛋白,CRP为C反应蛋白,IL-6为白介素-6,PCT为降钙素原
表3 血清I-FABP、D-乳酸及炎症因子在脓毒症相关急性胃肠损伤中的预测价值
[1]
金鑫.血乳酸/白蛋白与老年脓毒症合并急性胃肠功能损伤患者病情及预后的关系[J].山东医药, 2024, 64(11): 70-73.
[2]
姚钧,张茜利,宣娟娟,等.脓毒症合并急性胃肠损伤的危险因素分析[J].浙江创伤外科, 2022, 24(3): 444-445.
[3]
孟蕾,宋维鹏,刘秀娟,等.脓毒症预后不良患者血清I-FABP, DAO, D-Lac水平变化及其危险因素探讨[J].分子诊断与治疗杂志, 2023, 15(2): 265-268, 272.
[4]
上海市中西医结合学会急救专业委员会,上海市中西医结合学会重症医学专业委员会,上海市医师协会急诊科医师分会,等.脓毒症急性胃肠功能障碍中西医结合临床专家共识[J].中华危重病急救医学, 2022, 34(2): 113-120.
[5]
石庆玲,郭卫东,徐振兴.不同病原体类型脓毒症患者的临床特征及对预后的影响因素[J].中国病原生物学杂志, 2024, 19(11): 1317-1321, 1326.
[6]
Liu D, Huang SY, Sun JH, et al. Sepsis-induced immunosuppression: mechanisms, diagnosis and current treatment options[J]. Mil Med Res, 2022, 9(1): 56.
[7]
俞隼,许春阳,叶宏伟,等.急性胃肠损伤分级联合qSOFA评分在脓毒症诊断中的价值[J].中华急诊医学杂志, 2021, 30(11): 1358-1365.
[8]
杨思雯,李思耐,张鑫,等.脓毒症急性胃肠损伤危险因素分析及中医干预观察[J].世界中医药, 2022, 17(8): 1140-1144.
[9]
吕强,郑春和,桑云华.生长抑素联合前列地尔治疗老年脓毒症胃肠功能障碍的临床观察及对血清I-FABP、GSH-Px水平的影响[J].国际检验医学杂志, 2021, 42(21): 2679-2682.
[10]
童武进,顾魏峰,徐俊,等.血清肠型脂肪酸结合蛋白与胆碱酯酶联合检测在危重患者脓毒症诊断和预后中的价值[J].中国急救复苏与灾害医学杂志, 2024, 19(7): 887-891.
[11]
Yang K, Fan M, Wang X, et al. Lactate promotes macrophage HMGB1 lactylation, acetylation, and exosomal release in polymicrobial sepsis[J]. Cell Death Differ, 2022, 29(1): 133-146.
[12]
陈婕,张红梅,谭春艳.脓毒症患者肠道菌群生态特征与血清D-乳酸,sTREM1和MCP-1表达水平的相关性研究[J].现代检验医学杂志, 2023, 38(4): 139-142, 179.
[13]
彭婷婷,刘云红,轩凯.脓毒症患者炎症因子与内毒素变化和细菌类型及病情的关系研究[J].中华医院感染学杂志, 2020, 30(4): 487-491.
[14]
吴静静,张福森,李冬梅,等.血清Syndecan-1, Endocan-1及炎症因子评估脓毒症患者病情严重程度及预后的价值[J].检验医学与临床, 2024, 21(14): 2053-2056, 2061.
[15]
Nong Y, Wei X, Yu D. Inflammatory mechanisms and intervention strategies for sepsis-induced myocardial dysfunction[J]. Immun Inflamm Dis, 2023, 11(5): e860.
[16]
李荣新,方源,宋卫平.脓毒症合并肠缺血再灌注损伤患者血清肠脂肪酸结合蛋白,D乳酸和细胞间黏附因子1水平与肠黏膜损伤程度和预后的相关性[J].临床内科杂志, 2025, 42(1): 39-43.
[1] 潘驰, 姜伟, 孔弘扬, 倪清涛. 浆细胞性乳腺炎模型小鼠调节性B细胞分化情况[J/OL]. 中华乳腺病杂志(电子版), 2025, 19(05): 275-281.
[2] 王欢, 雷琳, 刘梦瑶, 朱娟娟, 郭王斌. 特发性肺纤维化患者血清LncRNA-GAS5、miR-221-3p与肺动脉高压的相关性研究[J/OL]. 中华危重症医学杂志(电子版), 2025, 18(05): 382-389.
[3] 张巍, 邵明亮, 孙建华, 戴世荣, 吴金娜. 结肠癌脓毒症患者外周血单个核细胞整合素αL甲基化特征[J/OL]. 中华实验和临床感染病杂志(电子版), 2025, 19(05): 271-278.
[4] 钱何布, 朱林, 姚月平, 姚峰, 李玉卓, 马家驹, 晏倩, 倪晓艳. 应用机器学习建立脓毒性休克患者住院28天死亡预测模型及验证[J/OL]. 中华实验和临床感染病杂志(电子版), 2025, 19(05): 288-297.
[5] 沈振, 周岩. 中间尾侧联合入路腹腔镜系膜切除对右半结肠癌并肠梗阻患者炎症与应激反应的影响[J/OL]. 中华普外科手术学杂志(电子版), 2026, 20(01): 34-37.
[6] 孟竹达, 靳亚杰, 郝冉, 赵二鹏. MMIF与围手术期指标预测甲状腺全切术后甲状旁腺功能减退的价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(06): 678-681.
[7] 陶然, 尹聪, 叶少波, 杨新平, 田洁, 熊丽红, 吴瑾滨, 梅红兵. 应用多学科管理预防日间经皮肾镜碎石取石术后尿源性脓毒症的发生[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(05): 615-621.
[8] 刘宝德, 郑娉娉, 肖宇翔, 沈凌, 王柳盛, 张维. 肺泡灌洗液中炎症因子对重症肺炎患者痰栓风险的预测分析[J/OL]. 中华肺部疾病杂志(电子版), 2025, 18(06): 917-922.
[9] 李兴华, 李桂仙, 刘颖, 耿红玉, 顾莹, 韩聪聪. 西维来司他钠联合甲泼尼龙琥珀酸钠、气道压力释放通气治疗对脓毒症所致急性呼吸窘迫综合征患者肺功能的影响[J/OL]. 中华肺部疾病杂志(电子版), 2025, 18(05): 789-795.
[10] 安嘉伟, 刘国臣, 朱俊宇, 盖新宇. 细胞焦亡在脓毒症相关肝损伤中的作用机制及干预药物的研究进展[J/OL]. 中华细胞与干细胞杂志(电子版), 2025, 15(06): 374-382.
[11] 李恺, 敖强国, 陶亚茹, 李青霖. 脓毒症相关急性肾损伤患者临床特点及90天预后影响因素分析[J/OL]. 中华肾病研究电子杂志, 2025, 14(05): 248-253.
[12] 刘理冠, 严彦, 陈惠玲, 吴金票, 黄志杰, 徐涛, 李勇飞, 叶巧霞. IL-6、GP73和CK-18片段与单纯性肝囊肿临床特点的相关性及临床预测价值[J/OL]. 中华消化病与影像杂志(电子版), 2025, 15(05): 486-491.
[13] 周懿, 黄容华, 刘政疆. 5-羟色胺与铁死亡介导的脓毒症心肌病的研究进展[J/OL]. 中华临床医师杂志(电子版), 2025, 19(08): 612-617.
[14] 宁雯琪, 张永利. 脓毒症心肌病的研究进展:基础、临床与展望[J/OL]. 中华临床医师杂志(电子版), 2025, 19(06): 461-466.
[15] 马涛, 赵焓宇, 王毅, 高晓明, 于湘友. 脓毒症相关的铁死亡研究知识图谱分析[J/OL]. 中华卫生应急电子杂志, 2025, 11(05): 299-309.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?